MTND1P6

Across TCGA pan-cancer cohorts, MTND1P6 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated MTND1P6 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MTND1P6 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND1P6 expression acts as an unfavorable survival marker.

KIRC, UVM, and ACC are the cancer types where MTND1P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.491	0.648	<.001	111	view →
UVM	DFS	Tertile	All	0.234	0.781	<.001	54	view →
ACC	DFS	Tertile	All	0.430	0.778	.009	54	view →
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	36	view →
THYM	OS	Tertile	All	0.480	0.902	.003	30	view →
PCPG	OS	Tertile	All	0.717	0.959	<.001	27	view →
GBM	DFS	Tertile	All	0.065	0.259	.002	18	view →
LIHC	DFS	Tertile	II,III,IV	0.077	0.463	.002	18	view →
LUSC	OS	Tertile	All	0.378	0.739	.003	18	view →
UCS	OS	Tertile	All	0.258	0.694	.008	18	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	9	view →
HNSC	DFS	Tertile	All	0.487	0.718	.012	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

MTND1P6–KIRC (DFS)

Open the KIRC breakdown →